Molecular patterns of multidrug resistance of Mycobacterium tuberculosis in Georgia

被引:10
|
作者
Shubladze, N. [1 ]
Tadumadze, N. [1 ]
Bablishvili, N. [1 ]
机构
[1] Natl Ctr TB & Lung Dis, Tbilisi, Georgia
关键词
M; tuberculosis; Mutation; Multidrug resistant tuberculosis; GenoType((R))MTBDRplus; Fitness cost;
D O I
10.1016/j.ijmyco.2013.02.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Tuberculosis (TB) infections caused by multidrug-resistant Mycobacterium tuberculosis (MDR MTB) remain a significant public health concern worldwide. Georgia has a high prevalence of MDR MTB. The genetic mechanisms underlying the emergence of MDR MTB strains in this region are poorly understood and need to be determined for developing better strategies for TB control. This study investigated the frequency of major drug resistance mutations across rpoB, katG and inhA loci of Georgian MDR MTB strains and explored differences between new and previously treated patients. A total of 634 MTB strains were examined for which an MDR phenotype had been previously determined by the proportions method. The Geno Type((R))MTBDRplus system was applied to screen the strains for the presence of rpoB (S531L, H526D, H526Y, and D516V), katG (S315T) and inhA promoter region (C15T and T8C) mutations. The target loci were amplified by PCR and then hybridized with the respective site-specific and wild type (control) probes. Results: Out of the 634 isolates tested considered by phenotypic testing to be resistant to RIF and INH, this resistance was confirmed by the GenoType((R))MTBDRplus assay in 575 (90.7%) isolates. RIF resistance was seen in 589 (92.9%) and INH resistance was seen in 584 (92.1%); 67.2% and 84.3% of MDR strains harbored respectively rpoB S531L and katG S315T mutations (generally known as having low or no fitness cost in MTB). The inhA C15T mutation was detected in 22.6% of the strains, whereas rpoB H526D, rpoB H526Y, rpoB D516V and inhA T8C were revealed at a markedly lower frequency (<= 5.2%). The specific mutations responsible for the RIF resistance of 110 isolates (17.4%) could not be detected as no corresponding mutant probe was indicated in the assay. There was no specific association of the presence of mutations with the gender/age groups. All types of prevailing mutations had higher levels in new cases. A great majority of the Georgian MDR MTB strains have a strong preference for the drug resistance mutations carrying no or low fitness cost. Thus, it can be suggested that MDR MTB strains with such mutations will continue to arise in Georgia at a high frequency even in the absence of antibiotic pressure. (C) 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [41] Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
    Che, Yang
    Bo, Dingyi
    Lin, Xiang
    Chen, Tong
    He, Tianfeng
    Lin, Yi
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [42] Genotyping and Molecular Characterization of Fluoroquinolone's Resistance Among Multidrug-Resistant Mycobacterium tuberculosis in Southwest of China
    Hu, Yan
    Liu, Jie
    Shen, Jing
    Feng, Xin
    Liu, Wenguo
    Zhu, Damian
    Zheng, Huiwen
    Hu, Daiyu
    MICROBIAL DRUG RESISTANCE, 2021, 27 (07) : 865 - 870
  • [43] Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia
    Figueroa, Maria Alvarez
    Ludannyy, Ruslan
    Popov, Sergey
    Mokrousov, Igor
    Vyazovaya, Anna
    Shipulin, German
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] Instability of IS6110 patterns in multidrug-resistant strains of Mycobacterium tuberculosis
    Farnia, P.
    Masjedi, M. R.
    Nasiri, B.
    Mirsaedi, M.
    Sorooch, S.
    Kazeampour, M.
    Velayati, A. A.
    EPIDEMIOLOGY AND INFECTION, 2007, 135 (02): : 346 - 352
  • [45] Probing the molecular basis of drug resistance in Mycobacterium tuberculosis
    Rodgers, KR
    Lukat-Rodgers, GS
    Rusnak, F
    Wengenack, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U966 - U966
  • [46] Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients
    Ahmad, Nafees
    Javaid, Arshad
    Sulaiman, Syed Azhar Syed
    Ming, Long Chiau
    Ahmad, Izaz
    Khan, Amer Hayat
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (01): : 41 - 47
  • [47] Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking
    Unissa, Amirudeen Nusrath
    Selvakumar, Nagamiah
    Hassan, Sameer
    BIOINFORMATION, 2009, 4 (01) : 24 - 29
  • [48] Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi
    Ndung'u, Perpetual Wangui
    Kariuki, Samuel
    Ng'ang'a, Zipporah
    Revathi, Gunturu
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (01): : 33 - 39
  • [49] Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers
    Nateche, F
    Martin, A
    Baraka, S
    Palomino, JC
    Khaled, S
    Portaels, F
    JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (07) : 857 - 860
  • [50] Molecular Characterization and Second-Line Antituberculosis Drug Resistance Patterns of Multidrug-Resistant Mycobacterium tuberculosis Isolates from the Northern Region of South Africa
    Said, Halima M.
    Kock, Marleen M.
    Ismail, Nazir A.
    Mphahlele, Matsie
    Baba, Kamaldeen
    Omar, Shaheed V.
    Osman, Ayman G.
    Hoosen, Anwar A.
    Ehlers, Marthie M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (09) : 2857 - 2862